Paper · 6133734
Newer antisecretory agents for peptic ulcer.
Somerville KW and 1 other. Drugs, 1983. Cited by 30 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Newer antisecretory agents for peptic ulcer. Papers, record 6133734. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6133734
On this page
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Ulcer Agents | Major topic |
| Gastric Juice | Major topic |
| Peptic Ulcer | Major topic |
| Dopamine | |
| Dopamine Antagonists | |
| Histamine H2 Antagonists | |
| Humans | |
| Parasympatholytics | |
| Prostaglandins | |
| Psychotropic Drugs |
Source PubMed
Grants0
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
None in this release.
Trials0
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
None in this release.
Comments and corrections0
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
None in this release.
References82
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 396,655 | Pirenzepine (LS 519) in severe duodenal ulcer and in gastric ulcer. A double-blind clinical trial. | Scand J Gastroenterol Suppl | 1979 | https://conductscience.org/library/papers/396655 | PubMed |
| 2 | 295,516 | The pharmacokinetic profile of pirenzepine. | Scand J Gastroenterol Suppl | 1979 | https://conductscience.org/library/papers/295516 | PubMed |
| 3 | 6,787,694 | Influence of intravenous pirenzepine on gastric acid and pepsin in man. | Scand J Gastroenterol Suppl | 1980 | https://conductscience.org/library/papers/6787694 | PubMed |
| 4 | 6,812,688 | Cimetidine and gastric cancer: preliminary report from post-marketing surveillance study. | Br Med J (Clin Res Ed) | 1982 | https://conductscience.org/library/papers/6812688 | PubMed |
| 5 | 6,941,379 | Effects of pirenzepine and atropine on gastric secretory and plasma hormonal responses to sham-feeding in patients with duodenal ulcer. | Scand J Gastroenterol Suppl | 1980 | https://conductscience.org/library/papers/6941379 | PubMed |
| 6 | 6,243,110 | Comparison of methionine-enkephalin and morphine in the stimulation of gastric acid secretion in the dog. | Gastroenterology | 1980 | https://conductscience.org/library/papers/6243110 | PubMed |
| 7 | 6,119,778 | Investigations on the penetration of ranitidine into the cerebrospinal fluid and a comparison of the effects of ranitidine and cimetidine on male sex hormones. | Scand J Gastroenterol Suppl | 1981 | https://conductscience.org/library/papers/6119778 | PubMed |
| 8 | 375,436 | Healing of peptic ulcers on conventional antacid therapy with or without butriptyline. | S Afr Med J | 1979 | https://conductscience.org/library/papers/375436 | PubMed |
| 9 | 387,498 | Clinical effects of trithiozine, a newer gastric anti-secretory agent. | J Int Med Res | 1979 | https://conductscience.org/library/papers/387498 | PubMed |
| 10 | 90,970 | Dopamine disorder in duodenal ulceration. | Lancet | 1979 | https://conductscience.org/library/papers/90970 | PubMed |
1 to 10 of 82
See all 82 referencesCited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 30 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 38,139,825 | From Selye's and Szabo's Cysteamine-Duodenal Ulcer in Rats to Dopamine in the Stomach: Therapy Significance and Possibilities. | Pharmaceuticals (Basel) | 2023 | https://conductscience.org/library/papers/38139825 | PubMed |
| 35,125,818 | Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome. | World J Gastroenterol | 2022 | https://conductscience.org/library/papers/35125818 | PubMed |
| 2,866,097 | Famotidine, a new H2-receptor antagonist, does not affect hepatic elimination of diazepam or tubular secretion of procainamide. | Eur J Clin Pharmacol | 1985 | https://conductscience.org/library/papers/2866097 | PubMed |
| 2,070,703 | Dopamine agonists prevent duodenal ulcer relapse. A comparative study with famotidine and cimetidine. | Dig Dis Sci | 1991 | https://conductscience.org/library/papers/2070703 | PubMed |
Genes0
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
None in this release.
Drugs0
The drugs whose trials, in the Pipelines release, list the paper.
None in this release.
Data0
The data bank entries PubMed's record names. Trial numbers are under Trials.
None in this release.
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6133734
GET https://conductscience.org/api/papers/v1/6133734/references?page=2